Sangtec licenses DxS's DNA detection technology:
This article was originally published in Clinica
Sangtec Molecular Diagnostics, based near Stockholm, Sweden, has licensed a fluorescence-based DNA detection and genotyping system developed by Manchester, UK-based DxS. The technology, called Scorpions, will be used in the development of new polymerase chain reaction (PCR) tests within Sangtec's focus areas of cancer and infectious disease.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.